Literature DB >> 856312

Inhibition of prolactin release by metergoline administration in man.

G Delitala, A Masala, S Alagna, L Devilla, P P Rovasio.   

Abstract

Oral administration of metergoline, an antiserotoninergic agent, produced a fall in plasma prolactin concentrations in normal subjects. Prolactin values remained suppressed during a five day course of treatment with the drug. Serum growth hormone values were not altered significantly.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 856312

Source DB:  PubMed          Journal:  Biomedicine        ISSN： 0300-0893


  4 in total

1.  Inhibition of cimetidine-induced hyperprolactinemia by pretreatment with metergoline.

Authors:  M Iodice; G Lombardi; A P Tommaselli; R Rossi; M Minozzi
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

2.  Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.

Authors:  M A Lee; J F Nash; M Barnes; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Receptor blocking drugs and amphetamine anorexia in human subjects.

Authors:  E Goodall; E Trenchard; T Silverstone
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.

Authors:  D Tepavcević; Z Giljević; M Korsić; S Halimi; E Suchanek; T Jelić; I Aganović; B Kozić; V Plavsić
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.